Application
Western blot analysis of KIR3DS1 Antibody (C-term) in K562 cell line lysates (35ug/lane). KIR3DS1 (arrow) was detected using the purified Pab.Application
KIR3DS1 Antibody (C-term) flow cytometric analysis of K562 cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Product Name | KIR3DS1 Antibody (C-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | KIR3DS1; NKAT10; Killer cell immunoglobulin-like receptor 3DS1; MHC class I NK cell receptor; Natural killer-associated transcript 10 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBFC |
| WB:1:100~500 FC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | NKAT10 |
|---|---|
| Alternative Names | KIR3DS1 NKAT10 Killer cell immunoglobulin-like receptor 3DS1 MHC class I NK cell receptor Natural killer-associated transcript 10 |
| Molecular Weight(MW) | 42902 Da |
| Function | Receptor on natural killer (NK) cells for HLA-C alleles. Does not inhibit the activity of NK cells |
| Tissue Specificity | Expressed in NK and T-cell lines but not in B- lymphoblastoid cell lines or in a colon carcinoma cell line |
| Cellular Localization | Cell membrane; Single-pass type I membrane protein |
Application
Western blot analysis of KIR3DS1 Antibody (C-term) in K562 cell line lysates (35ug/lane). KIR3DS1 (arrow) was detected using the purified Pab.
Application
KIR3DS1 Antibody (C-term) flow cytometric analysis of K562 cells (right histogram) compared to a negative control cell (left histogram).FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.| Application Notes | WB:1:100~500 FC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
